RESPONSIBLE PROVIDER IN ACCORDANCE WITH § 5 OF THE GERMAN TELEMEDIA ACT (TMG)
MorphoSys AG
Semmelweisstr. 7
82152 Planegg
Germany
Telephone: +49 89 899 27-0
Fax: +49 89 899 27-222
Email: info@morphosys.com
RESPONSIBLE IN ACCORDANCE WITH § 18 PARA 2 OF THE GERMAN INTERSTATE TREATY ON BROADCASTING [MEDIENSTAATSVERTRAG – MSTV]
Charlotte Lohmann (Chief Legal and Human Resources Officer)
MorphoSys AG
MANAGEMENT BOARD
Jean-Paul Kress, M.D. (Chairman, CEO) and Lucinda Crabtree, Ph.D. (CFO)
CHAIRMAN OF THE SUPERVISORY BOARD
Marc Cluzel, M.D., Ph.D.
COMMERCIAL REGISTER
District Court of Munich, HRB 121023
VAT ID NO.
DE 155069821
REGULATORY AUTHORITY
Government of Upper Bavaria
REGISTERED TRADEMARKS
HuCAL®, HuCAL GOLD®, HuCAL PLATINUM®, Ylanthia® and 100 billion high potentials® are trademarks of the MorphoSys Group. Monjuvi® and Minjuvi® are trademarks of Incyte. Tremfya® is a trademark of Janssen Biotech, Inc.
DESIGN & PROGRAMMING
Digitas Pixelpark
www.digitaspixelpark.com
For better understandability, the use of male and female language forms is avoided. All personal descriptions apply equally to all genders.